StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a report published on Friday morning. The firm issued a hold rating on the stock.
TherapeuticsMD Price Performance
Shares of NASDAQ TXMD opened at $1.64 on Friday. TherapeuticsMD has a 52-week low of $1.43 and a 52-week high of $3.07. The business’s 50 day moving average is $1.72 and its two-hundred day moving average is $1.89.
TherapeuticsMD (NASDAQ:TXMD – Get Free Report) last released its earnings results on Monday, August 12th. The company reported ($0.09) earnings per share (EPS) for the quarter. The company had revenue of $0.23 million during the quarter.
Institutional Investors Weigh In On TherapeuticsMD
TherapeuticsMD Company Profile
TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.
Recommended Stories
- Five stocks we like better than TherapeuticsMD
- Roth IRA Calculator: Calculate Your Potential Returns
- 3 Key Stocks to Ride China’s Stimulus-Driven Growth
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 3 Dividend Growth Stocks Set to Supercharge Your Portfolio
- Why Are These Companies Considered Blue Chips?
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.